• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

liver disease - Articles and news items

NICE recommends liver disease drug

Industry news / 21 March 2017 / Niamh Marriott, Junior Editor

NICE has published draft guidance which recommends Ocaliva, also known as obeticholic acid, for people with the chronic liver disease…

FDA grants fast track for Shire’s NASH investigational treatment

FDA grants fast track for Shire’s NASH investigational treatment

Industry news / 29 July 2016 / Mandy Parrett, Editorial Assistant

Shire Plc has announced today that the United States Food and Drug Administration (FDA) has granted Fast Track designation for SHP626 (volixibat) for an investigational treatment of adults with nonalcoholic steatohepatitis (NASH) with liver fibrosis.

 

Webinar: Understanding ISO Standards: ISO 14644-2:2015 Cleanroom MonitoringWATCH NOW
+ +